|
ZMPSTE24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22044604925031E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.98050999999921E-05 |
| Normal-vs-Stage3 |
3.959100E-04 |
| Normal-vs-Stage4 |
7.282400E-02 |
| Stage1-vs-Stage2 |
6.474800E-01 |
| Stage1-vs-Stage3 |
2.449200E-01 |
| Stage1-vs-Stage4 |
3.843000E-01 |
| Stage2-vs-Stage3 |
6.153000E-01 |
| Stage2-vs-Stage4 |
6.272400E-01 |
| Stage3-vs-Stage4 |
9.211000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
7.67929999589967E-08 |
| Normal-vs-Asian |
2.932400E-01 |
| Caucasian-vs-AfricanAmerican |
9.640600E-01 |
| Caucasian-vs-Asian |
6.544200E-01 |
| AfricanAmerican-vs-Asian |
5.842600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.77050000002865E-06 |
| Male-vs-Female |
2.840400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.197800E-04 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.64868119156836E-12 |
| Normal-vs-Extreme_Obese |
1.300400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.988400E-02 |
| Normal_Weight-vs-Obese |
2.757800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.552600E-01 |
| Extreme_Weight-vs-Obese |
2.531000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.028980E-01 |
| Obese-vs-Extreme_Obese |
3.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.603900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.99615887655591E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
8.397800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.269600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.695800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.193800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.672800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.336600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.827400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
8.987200E-04 |
| Normal-VS-KIRP CIMP |
3.335900E-03 |
| Normal-VS-Unclassified PRCC |
2.01400000010565E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.042600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.760600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.064300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.184400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.935380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.854000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.20750015226201E-10 |
| Normal-vs-N1 |
5.038900E-03 |
| Normal-vs-N2 |
2.041200E-01 |
| N0-vs-N1 |
3.217000E-01 |
| N0-vs-N2 |
8.051600E-01 |
| N1-vs-N2 |
8.396600E-01 |
|
|
